◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › ECL

Ecolab Inc (ECL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · Specialty Chemicals · DATA UPDATED 2026-07-13

Ecolab Inc (ECL) operates in the Specialty Chemicals industry and is headquartered in Saint Paul, United States with about 48,000 employees. Its market capitalization is roughly $76 billion. In the fiscal year ended 2025-12-31, ECL reported $16.1B in revenue and $2.1B in net income.

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences.

Interactive charts & full statements → Open the ECL valuation workbench →

ECL Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$16.5B$16.1B$15.7B$15.3B$14.2B$12.7B$11.8B$12.6B$14.7B$13.8B$13.2B$13.5B$14.3B$13.3B$11.8B$6.8B$6.1B$5.9B$6.1B$5.5B$4.9B
Gross Profit$7.3B$7.2B$6.8B$6.2B$5.4B$5.2B$4.9B$5.5B$6.1B$5.8B$6.3B$6.4B$6.6B$6.1B$5.4B$3.4B$3.1B$2.9B$3.0B$2.8B$2.5B
Gross Margin %44.3%44.5%43.5%40.3%38.2%41.0%41.5%44.0%41.3%42.1%47.9%47.0%46.3%45.7%46.0%49.3%50.6%49.6%48.8%50.8%50.6%
Operating Income (EBIT)$2.9B$2.9B$2.6B$2.2B$1.6B$1.7B$1.7B$1.9B$2.0B$2.2B$2.0B$2.0B$2.0B$1.8B$1.5B$928M$823M$750M$738M$687M$612M
Operating Margin %17.5%18.1%16.6%14.1%11.3%13.2%14.5%15.2%13.5%15.9%15.3%14.6%14.2%13.4%12.9%13.6%13.5%12.7%12.0%12.6%12.5%
Net Income$2.1B$2.1B$2.1B$1.4B$1.1B$1.1B($1.2B)$1.6B$1.4B$1.5B$1.2B$1.0B$1.2B$968M$704M$462M$530M$417M$448M$427M$369M
Net Margin %12.8%12.9%13.4%9.0%7.7%8.9%-10.2%12.4%9.7%10.9%9.3%7.4%8.4%7.3%5.9%6.8%8.7%7.1%7.3%7.8%7.5%
EBITDA$3.5B$3.5B$3.8B$3.0B$2.5B$2.5B$2.2B$2.7B$3.0B$2.9B$2.8B$2.4B$2.8B$2.4B$2.0B$1.1B$1.2B$1.0B$1.1B$965M$887M
Earnings Per Share (EPS)$7.40$7.28$7.37$4.79$3.81$3.91$-4.20$5.33$4.88$5.12$4.14$3.32$3.93$3.16$2.35$1.91$2.23$1.74$1.80$1.70$1.43
Shares Outstanding (M)284M285M287M286M287M289M287M292M293M294M297M301M306M306M299M242M238M240M249M252M257M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$4.1B$4.2B$4.2B$4.0B$3.7B$4.0B$4.0B$4.0B
Gross Profit$1.8B$1.8B$1.9B$1.8B$1.6B$1.7B$1.7B$1.7B
Gross Margin %43.5%44.0%44.8%44.8%44.3%43.4%43.4%43.8%
Operating Income (EBIT)$622M$786M$760M$710M$587M$686M$707M$673M
Operating Margin %15.3%18.7%18.2%17.6%15.9%17.1%17.7%16.9%
Net Income$433M$564M$585M$524M$402M$473M$736M$491M
Net Margin %10.6%13.4%14.1%13.0%10.9%11.8%18.4%12.3%
EBITDA$876M$903M$789M$978M$818M$848M$1.3B$906M
Earnings Per Share (EPS)$1.52$1.98$2.05$1.84$1.41$1.66$2.58$1.71
Shares Outstanding (M)284M284M285M285M285M286M286M287M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$3.0B$3.0B$2.8B$2.4B$1.8B$2.1B$1.9B$2.4B$2.3B$2.1B$1.9B$2.0B$1.8B$1.6B$1.2B$686M$950M$695M$753M$798M$628M
Capital Expenditures (CapEx)$1.2B$1.0B$994M$775M$713M$643M$489M$731M$847M$869M$757M$815M$794M$662M$608M$366M$298M$297M$394M$362M$321M
Free Cash Flow (FCF)$1.9B$1.9B$1.8B$1.6B$1.1B$1.4B$1.4B$1.7B$1.4B$1.2B$1.2B$1.2B$1.0B$898M$596M$320M$653M$398M$359M$436M$307M
FCF Margin %11.4%11.8%11.6%10.7%7.6%11.1%11.6%13.5%9.8%8.8%9.0%8.8%7.1%6.8%5.0%4.7%10.7%6.7%5.8%8.0%6.3%
Dividends Paid$778M$754M$664M$617M$603M$566M$561M$553M$496M$449M$428M$401M$344M$218M$307M$163M$146M$133M$128M$114M$101M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$446M$1.1B$791M$702M$369M$767M$787M$611M
Capital Expenditures (CapEx)$348M$332M$262M$217M$238M$360M$236M$197M
Free Cash Flow (FCF)$97M$758M$530M$485M$132M$407M$550M$414M
FCF Margin %2.4%18.1%12.7%12.0%3.6%10.2%13.8%10.4%
Dividends Paid$216M$189M$184M$188M$192M$161M$162M$166M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ECL Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$25.0B$24.7B$22.4B$21.8B$21.5B$21.2B$18.1B$20.9B$20.1B$20.0B$18.3B$18.6B$19.5B$19.6B$17.6B$18.2B$4.9B$5.0B$4.8B$4.7B$4.4B
Cash & Cash Equivalents$520M$646M$1.3B$920M$599M$360M$1.3B$119M$115M$211M$327M$93M$210M$339M$1.2B$1.8B$242M$74M$67M$137M$484M
Total Liabilities$15.0B$14.9B$13.6B$13.8B$14.2B$14.0B$11.9B$12.1B$12.0B$12.3B$11.4B$11.7B$12.1B$12.2B$11.4B$12.5B$2.7B$3.0B$3.2B$2.8B$2.7B
Total Debt (Short + Long-Term)$8.7B$8.2B$7.7B$8.3B$8.7B$8.9B$6.8B$6.5B$7.0B$7.3B$6.7B$6.5B$6.6B$6.9B$6.5B$7.6B$846M$967M$1.1B$1.0B$1.1B
Total Shareholders' Equity$10.0B$9.8B$8.8B$8.0B$7.2B$7.2B$6.2B$8.7B$8.0B$7.6B$6.9B$6.9B$7.3B$7.3B$6.1B$5.7B$2.1B$2.0B$1.6B$1.9B$1.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ECL viewer.

Other Companies in Specialty Chemicals

← ECHOAll stocksECO →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.